MDMA Moves from Party Drug Back to Therapy To...

In this episode of Science Quickly, one of SciAm’s Young American Scientists, biologist Jaye Gardiner, explores how common viral infections may raise cancer risk—not just through genetic mutations but by reshaping the body’s “extracellular matrix” of molecules that support cells ...  Show more

In this episode, host Rachel Feltman interviews neuroscientist Kauê M. Costa, who is among Scientific American’s inaugural cohort of Young American Scientists honorees. Costa shares how being surprised by experiments has led him to new ways of thinking about learning in the brain ...  Show more

Rick Doblin, psychotherapist and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), returns to chat about methylenedioxymethamphetamine (MDMA) and its positive effects on PTSD and trauma.Today, Doblin share what MDMA is, how it ...  Show more

In this episode, I discuss Methyl​enedioxy​methamphetamine (MDMA), which is also commonly known as “ecstasy” or “molly,” including how it works in the brain to cause short- and long- term-shifts in emotional processing and its clinical applications for the treatment of post-traum ...  Show more

Once a party drug, ketamine has found its way into modern medicine. 

In the form of recreational ecstasy, the psychoactive drug MDMA carries with it a stigma of wide-eyed ravers, free love and counterculture pharmacological spirituality. But beyond its cultural legacy, MDMA offers a potent therapeutic tool for doctors and therapists -- if we ca ...